Annex D Application Form For Foreign Manufacturer GMP Inspection
Annex D Application Form For Foreign Manufacturer GMP Inspection
Annex D Application Form For Foreign Manufacturer GMP Inspection
• This form should be completed by the drug importer for each Foreign Drug
Manufacturer.
• Incomplete forms may be returned to the applicant. Please type or print in black pen.
• Any alterations must be initialed and dated.
• The completed form should be sent to:
1
SECTION A
SPONSOR NAME:
SPONSOR ADDRESS:
CONTACT NAME:
TELEPHONE NO.:
FAX NO:
EMAIL ADDRESS:
Note: The sponsors must pay the cost of the inspection (based on the current fees and
charges) before the FDA GMP inspector leaves the Philippines, and the
manufacturer must agree to the inspection. Otherwise, the inspection will not
proceed.
SECTION B
TO BE COMPLETED BY OR ON BEHALF OF THE FOREIGN MANUFACTURER
MANUFACTURER’S NAME
OFFICE ADDRESS:
CONTACT NAME:
TELEPHONE NO.:
FAX NO:
EMAIL ADDRESS:
SECTION B-1
PRODUCT DETAILS –Specify Specify the steps in manufacture that are Sterile
type of product to be inspected, eg conducted at this site, eg all steps in Yes/no
tablet, herbal tablet, capsules, cream, manufacture, packaging, release,
herbal extracts, condoms, gloves etc manufacture of dosage form etc
Assembly:
Name:
*National Identification Number/Passport No.:
Designation:
Directly reporting to:
No. of years of relevant experience:
2. Person in charge of quality control *and/*or quality assurance.
Quality Control:
Name:
Quality assurance:
Name:
*National Identification Number/Passport No.:
Designation:
Directly reporting to:
No. of years of relevant experience:
3. Person who authorizes the release of products
Name:
*National Identification Number/Passport No.:
Designation:
Directly reporting to:
No. of years of relevant experience:
SECTION B-3
CONTRACT MANUFACTURER/ASSEMBLER INFORMATION
Company address:
Telephone No.:
Fax No.:
Telephone No.:
Fax No.:
Address:
Telephone No:
Fax No:
In the past, it was normal for the inspectors to spend some time, while on site, gathering this
information. To reduce inspection time, and obvious expense to the inspectee, it is expected
that this information should be prepared, in the form of a 'Site Master File' for a medical
product manufacturer, or a 'Quality Manual' for a medical device manufacturer, by the
inspectee for use by FDA GMP Inspectors.
It is requested that the Site Master File/ Quality Manual be enclosed, prepared and forward
these documents as soon as possible to the FDA Philippines.
For further information or queries regarding this application contact the following: